Pinterest Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Pinterest Inc trades at $20.5 (market cap $11.50B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Pinterest Inc is far larger — about 2.9× Relay Therapeutics Inc. Common Stock's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Pinterest Inc for 85 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PINS | RLAY | |
|---|---|---|
Market Cap | $11.50B | $3.94B |
Volume | 14,342,125 | 3,432,928 |
Sector | Media | Health |
52-Week High | $35.24 | $20.75 |
52-Week Low | $15.42 | $6.03 |
Typical Hold Time | 85 Days | 0 Days |
Enterprise Value | $11.42B | $3.06B |
Signals from Pluang's Aura AI — not financial advice
Pinterest (PINS) trades at $20.525, up 2.47% today, with a bullish technical signal despite mixed moving averages. Recent earnings have consistently beaten estimates, with Q2 2026 EPS of $0.43 exceeding the $0.36 forecast. Revenue growth is robust, rising from $2.8B in 2022 to $4.2B in 2025, though net income margins have moderated. The company's Visual Search Ads launch aims to enhance its advertising moat, supporting future monetization.
The stock presents a compelling opportunity with a consensus price target of $27.93, implying significant upside, and strong analyst support (54% buy ratings). However, risks include high valuation multiples, insider selling, and reliance on ad revenue growth amid competitive pressures. Execution on international monetization remains critical for sustained gains.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →